关注
Dr Polly Livermore
Dr Polly Livermore
NIHR, BRC, GOSH, UCL
在 ucl.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 …
P Woo, N Wilkinson, AM Prieur, T Southwood, V Leone, P Livermore, ...
Arthritis research & therapy 7 (6), R1281, 2005
3122005
Harper's Textbook of pediatric dermatology
AD Irvine, PH Hoeger, AC Yan
John Wiley & Sons, 2011
131*2011
British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy
AGS Oldroyd, JB Lilleker, T Amin, O Aragon, K Bechman, V Cuthbert, ...
Rheumatology, 2022
732022
Anti‐tumour necrosis factor therapy associated with cutaneous vasculitis
PA Livermore, KJ Murray
Rheumatology 41 (12), 1450-1452, 2002
552002
Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000–2007)
M Abinun, TJ Flood, AJ Cant, P Veys, AR Gennery, HE Foster, M Friswell, ...
Molecular immunology 47 (1), 46-51, 2009
522009
Juvenile dermatomyositis. Where are we now?
LJ McCann, P Livermore, MGL Wilkinson, LR Wedderburn
Clin Exp Rheumatol 40, 394-403, 2022
422022
Being on the juvenile dermatomyositis rollercoaster: a qualitative study
P Livermore, S Gray, K Mulligan, JN Stinson, LR Wedderburn, F Gibson
Pediatric Rheumatology 17 (1), 30, 2019
352019
Teaching home administration of sub-cutaneous methotrexate
P Livermore
Paediatric Nursing 15 (3), 28, 2003
182003
The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
P Livermore, D Eleftheriou, LR Wedderburn
Pediatric Rheumatology 14 (1), 21, 2016
142016
You give me a name that I can’t say, but I have to explain what it is every day: the power of poetry to share stories from young people with a rare disease
P Livermore, LR Wedderburn, F Gibson
Journal of Poetry Therapy 33 (1), 20-29, 2020
92020
Oxford handbook of musculoskeletal nursing
SMO OBE
Oxford University Press, 2020
72020
Development of a benchmarking toolkit for adolescent and young adult rheumatology services (BeTAR)
RA Cai, H Chaplin, P Livermore, M Lee, D Sen, LR Wedderburn, ...
Pediatric Rheumatology 17 (1), 1-11, 2019
72019
Assessing Psychosocial Needs in Juvenile Dermatomyositis Patients Across the United Kingdom
P Livermore, L Wedderburn
ARTHRITIS & RHEUMATOLOGY 71, 2019
72019
Mapping the current psychology provision for children and young people with juvenile dermatomyositis
P Livermore, F Gibson, K Mulligan, LR Wedderburn, LJ McCann, S Gray
Rheumatology Advances in Practice 5 (3), rkab062, 2021
62021
Juvenile idiopathic arthritis: updated guide to administering methotrexate
P Livermore
Nursing children and young people 26 (1), 2014
52014
A survey to understand the feelings towards and impact of COVID-19 on the households of juvenile dermato myositis patients from a parent or carer perspective
MGL Wilkinson, W Wu, K O’Brien, CT Deakin, LR Wedderburn, ...
Rheumatology advances in practice 5 (3), rkab058, 2021
32021
Administering Subcutaneous Methotrexate for Inflammatory Arthritis: RCN Guidance
Royal College of Nursing
RCN, 2016
22016
Experience of one UK site presenting a closer examination of safety and efficacy of Anakinra (Kineret®) in systemic juvenile idiopathic arthritis
P Livermore, P Woo
Pediatric Rheumatology 6 (S1), P32, 2008
22008
Towards a consensus for nurse education of methotrexate for people with rheumatic and musculoskeletal diseases: A scoping review
A Marques, C Matos, E Nikiphorou, P Livermore, RJO Ferreira
Musculoskeletal Care, 0
2
OP0306-HPR POINTS TO CONSIDER FOR PATIENT EDUCATION PROVIDED BY NURSES ON METHOTREXATE USE. A EUROPEAN CONSENSUS INITIATIVE
A Marques, P Livermore, U Martin, A Ludvigsen, K El Aoufy, C Matos, ...
Annals of the Rheumatic Diseases 82 (Suppl 1), 198-199, 2023
12023
系统目前无法执行此操作,请稍后再试。
文章 1–20